CO4480720A1 - Procedimiento para la separacion de 1-azabiciclo[2.2.2]octan -3-amina, 2-(difenilmetil)-n-[[2-metoxi-5-(1-metiletil)fe- nil]metil]. - Google Patents

Procedimiento para la separacion de 1-azabiciclo[2.2.2]octan -3-amina, 2-(difenilmetil)-n-[[2-metoxi-5-(1-metiletil)fe- nil]metil].

Info

Publication number
CO4480720A1
CO4480720A1 CO96037152A CO96037152A CO4480720A1 CO 4480720 A1 CO4480720 A1 CO 4480720A1 CO 96037152 A CO96037152 A CO 96037152A CO 96037152 A CO96037152 A CO 96037152A CO 4480720 A1 CO4480720 A1 CO 4480720A1
Authority
CO
Colombia
Prior art keywords
methyl
azabiciclo
octan
amine
phenyl
Prior art date
Application number
CO96037152A
Other languages
English (en)
Inventor
L Derek Tickner
Meltz Morgan
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CO4480720A1 publication Critical patent/CO4480720A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)

Abstract

ESTA INVENCION SE REFIERE A UN PROCEDIMIENTO PARA SEPARAR 1-AZABICICLO [2.2.2]OCTAN-3-AMINA, 2-(DI- FENILMETIL)-N-[[2-METOXI-5-(1-METILETIL)FENIL]ME- TIL] QUE COMPRENDE HACER REACCIONAR 1-AZABICICLO [2.2.2]OCTAN-3-AMINA, 2-(DIFENILMETIL)-N-[[2-METO- XI-5-(1 METILETIL)FENIL]METIL] CON ACIDO 1R-(-)-10 -CANFORSULFONICO EN UN DISOLVENTE CAPAZ DE DISOL- VER AMBOS REACTIVOS ANTERIORES Y DISOLVER DE FORMA SELECTIVA LA SAL DE ACIDO CANFORSULFONICO DEL ENANTIOMERO (2R, 3R) CORRESPONDIENTE RESPECTO AL ENANTIOMERO (2S, 3S) PARA FORMAR LA SAL DE ACIDO CANFORSULFONICO DE (2S, 3S)-1-AZABICICLO [2.2.2] OCTAN-3AMINA, 2-(DIFENILMETIL)-N-[[2-METOXI-5-(1- METILETIL)FENIL]METIL], Y SEGUIDAMENTE HIDROLIZAR DE FORMA OPCIONAL DICHA SAL PARA OBTENER LA BASE LIBRE DEL ENANTIOMERO (2S, 3S).
CO96037152A 1995-07-17 1996-07-15 Procedimiento para la separacion de 1-azabiciclo[2.2.2]octan -3-amina, 2-(difenilmetil)-n-[[2-metoxi-5-(1-metiletil)fe- nil]metil]. CO4480720A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US119195P 1995-07-17 1995-07-17

Publications (1)

Publication Number Publication Date
CO4480720A1 true CO4480720A1 (es) 1997-07-09

Family

ID=21694832

Family Applications (1)

Application Number Title Priority Date Filing Date
CO96037152A CO4480720A1 (es) 1995-07-17 1996-07-15 Procedimiento para la separacion de 1-azabiciclo[2.2.2]octan -3-amina, 2-(difenilmetil)-n-[[2-metoxi-5-(1-metiletil)fe- nil]metil].

Country Status (26)

Country Link
US (1) US6008357A (es)
EP (1) EP0840735B1 (es)
JP (1) JP3043074B2 (es)
KR (1) KR100276989B1 (es)
CN (1) CN1068598C (es)
AR (1) AR002772A1 (es)
AT (1) ATE250600T1 (es)
AU (1) AU697553B2 (es)
CA (1) CA2227194C (es)
CO (1) CO4480720A1 (es)
CZ (1) CZ15098A3 (es)
DE (1) DE69630123T2 (es)
DK (1) DK0840735T3 (es)
ES (1) ES2205039T3 (es)
HK (1) HK1010195A1 (es)
HU (1) HUP9900238A3 (es)
IL (1) IL122655A0 (es)
MY (1) MY115734A (es)
NO (1) NO980211L (es)
NZ (1) NZ310539A (es)
PE (1) PE8798A1 (es)
PL (1) PL184261B1 (es)
PT (1) PT840735E (es)
RU (1) RU2136681C1 (es)
WO (1) WO1997003984A1 (es)
ZA (1) ZA966026B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861526B2 (en) 2002-10-16 2005-03-01 Pfizer Inc. Process for the preparation of (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine
SI1713801T1 (sl) * 2004-02-02 2008-04-30 Pfizer Prod Inc Postopek priprave 1-(2S,3S)-2-benzhidril-N-(5-terc-butil-2-metoksibenzil)kinuklidin-3- amina
CA2581863A1 (en) * 2004-11-10 2006-05-26 Boehringer Ingelheim Chemicals, Inc. Process of making fentanyl intermediates
JP2012511585A (ja) * 2008-12-09 2012-05-24 ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイテッド キナーゼ阻害化合物
US20160332962A1 (en) 2015-05-13 2016-11-17 Janssen Pharmaceutica Nv (s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
CN108341812A (zh) * 2017-01-23 2018-07-31 科贝源(北京)生物医药科技有限公司 一种含奎宁环化合物的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990005525A1 (en) * 1988-11-23 1990-05-31 Pfizer Inc. Quinuclidine derivatives as substance p antagonists
NO168529C (no) * 1989-09-15 1992-03-04 Chiron Lab As Fremgangsmaate for fremstilling av s-(-) og r-(+)-n-(quinuclidinyl-3)-amider.
DE69232334T2 (de) * 1991-05-22 2002-11-14 Pfizer Inc., New York Substituierte 3-aminochinuclidine
DK0587723T3 (da) * 1991-05-31 1996-04-01 Pfizer Quinuclidinderivater
US5604241A (en) * 1992-10-21 1997-02-18 Pfizer Inc. Substituted benzylaminoquinuclidines as substance P antagonists

Also Published As

Publication number Publication date
HUP9900238A3 (en) 2001-08-28
HK1010195A1 (en) 1999-06-17
ZA966026B (en) 1998-01-16
HUP9900238A2 (hu) 1999-05-28
NO980211L (no) 1998-03-16
US6008357A (en) 1999-12-28
PL184261B1 (pl) 2002-09-30
EP0840735A1 (en) 1998-05-13
WO1997003984A1 (en) 1997-02-06
NZ310539A (en) 1998-11-25
CA2227194A1 (en) 1997-02-06
AR002772A1 (es) 1998-04-29
DE69630123T2 (de) 2004-04-08
CZ15098A3 (cs) 1999-02-17
IL122655A0 (en) 1998-08-16
ATE250600T1 (de) 2003-10-15
KR100276989B1 (ko) 2001-01-15
JP3043074B2 (ja) 2000-05-22
AU697553B2 (en) 1998-10-08
RU2136681C1 (ru) 1999-09-10
MY115734A (en) 2003-08-30
CA2227194C (en) 2002-02-12
PT840735E (pt) 2004-02-27
KR19990029058A (ko) 1999-04-15
NO980211D0 (no) 1998-01-16
EP0840735B1 (en) 2003-09-24
ES2205039T3 (es) 2004-05-01
CN1190970A (zh) 1998-08-19
AU6134896A (en) 1997-02-18
JPH10511102A (ja) 1998-10-27
CN1068598C (zh) 2001-07-18
DE69630123D1 (en) 2003-10-30
PE8798A1 (es) 1998-03-02
MX9800538A (es) 1998-05-31
DK0840735T3 (da) 2004-02-09
PL324610A1 (en) 1998-06-08

Similar Documents

Publication Publication Date Title
PT871894E (pt) Capsula modular para reagentes
BR0108213A (pt) Compostos de cahalalida
FR2719212B1 (fr) Système de guidage à double clou pour la visée des trous pour vis distale des clous d'emboîtement.
BR9605906A (pt) Compostos benzo-heterociclicos substituídos por aminoalquila utilizaçao processo para sua fabricaçao e agentes com açao antimicótica e redutora do colesterol contendo os mesmos
AR038434A2 (es) Compuesto 14,15-dihidro-16-oxoparahercuamida y compuestos 2-desoxo de parahercuamida y marcfortina
AR022906A1 (es) Amidas de aminoacidos modificadas, medicamentos que contienen estos compuestos y procedimiento para su preparacion
DE69534729D1 (de) Verfahren zur Anfragelenkung für eine virtuelle Verbindung in Abhängigkeit vor Informationen über gleichzeitige Anfragen
PT83440B (pt) Processo para a preparacao de 2-oxo-1-{ {(sulfonil substituido)amino}carbonil}azetidinas
FR2749323B1 (fr) Pseudo-particules virales utiles en tant que vecteur de delivrance d'acide nucleique
CO4480720A1 (es) Procedimiento para la separacion de 1-azabiciclo[2.2.2]octan -3-amina, 2-(difenilmetil)-n-[[2-metoxi-5-(1-metiletil)fe- nil]metil].
BR0311242A (pt) Processo para preparar modafinil
BR9815469A (pt) Inibidores de protease
PT86820A (pt) Processo para a preparacao de novos compostos derivados do tetrazol com actividade antihipercolesterolemica
ES2184304T3 (es) Procedimiento de preparacion de un perhidro-isoindol sustituido.
ES2103253T3 (es) Procedimiento para la preparacion de un dicloruro de acido dicarboxilico.
BR9812773A (pt) "alfa-amino-epsilon-caprolactamas policìclicas e compostos relacionados"
BR9812085A (pt) "método para a sìntese de derivados de quinolina"
BR9705456A (pt) Compostos heterocìclicos, processo de aminometila para sua preparação e composições farmacêuticas que os contêm.
DE69409103D1 (de) Schnelleinschaltende quelle für faseroptischen kreisel
BR9807265A (pt) Processo de epoxidação seletiva para preparação de compostos farmacêuticos
EA200000859A1 (ru) Способ синтеза ингибиторов протеазы вич
PT1015415E (pt) Novos processos estereosselectivos para a preparacao de analogos de gabapentina
BR9712805A (pt) Processo para a preparação de compostos farmecêuticos
ATE268753T1 (de) Verfahren zur herstellung von 24(s)- hydroxyvitamin d2
BR9809439A (pt) Processos para preparação de benzotiofenos